Literature DB >> 29486376

Markers of anaphylaxis - a systematic review.

Maria Magdalena Tomasiak-Łozowska1, Maciej Klimek1, Agnieszka Lis1, Marcin Moniuszko2, Anna Bodzenta-Łukaszyk3.   

Abstract

Anaphylaxis is defined as severe, life-threatening, systemic or general, immediate reaction of hypersensitivity, with repeatable symptoms caused by the dose of stimulus which is well tolerated by healthy persons. The proper diagnosis, immediate treatment and differential diagnosis are crucial for saving patient's life. However, anaphylaxis is relatively frequently misdiagnosed or confused with other clinical entities. Thus, there is a continuous need for identifying detectable markers improving the proper diagnosis of anaphylaxis. Here we presented currently known markers of anaphylaxis and discussed in more detail the most clinically valuable ones: tryptase, platelet activacting factor (PAF), PAF-acethylhydrolase, histamine and its metabolites.
Copyright © 2017 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Histamine; Mast cell; Platelet activating factor; Tryptase

Mesh:

Substances:

Year:  2018        PMID: 29486376     DOI: 10.1016/j.advms.2017.12.003

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  6 in total

1.  Drug-Induced Anaphylaxis in a Vietnamese Pharmacovigilance Database: Trends and Specific Signals from a Disproportionality Analysis.

Authors:  Khac-Dung Nguyen; Hoang-Anh Nguyen; Dinh-Hoa Vu; Thi Thuy-Linh Le; Hoang-Anh Nguyen; Bich-Viet Dang; Trung-Nguyen Nguyen; Dang-Hoa Nguyen; Thanh-Binh Nguyen; Jean-Louis Montastruc; Haleh Bagheri
Journal:  Drug Saf       Date:  2019-05       Impact factor: 5.606

2.  The Protein Level and Molecular Weight Analysis in Different Children's Toothpaste, which Probably Induced Hypersensitivity.

Authors:  Hendrik Setia Budi; Indah Pebriani
Journal:  Contemp Clin Dent       Date:  2020-11-26

Review 3.  Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.

Authors:  Peter Valent; Cem Akin; Boguslaw Nedoszytko; Patrizia Bonadonna; Karin Hartmann; Marek Niedoszytko; Knut Brockow; Frank Siebenhaar; Massimo Triggiani; Michel Arock; Jan Romantowski; Aleksandra Górska; Lawrence B Schwartz; Dean D Metcalfe
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

4.  Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study.

Authors:  Diego Alvarado; Marcus Maurer; Richard Gedrich; Scott B Seibel; Michael B Murphy; Linda Crew; Joel Goldstein; Andrea Crocker; Laura A Vitale; Pamela A Morani; Lawrence J Thomas; Thomas R Hawthorne; Tibor Keler; Diane Young; Elizabeth Crowley; Martin Kankam; Margo Heath-Chiozzi
Journal:  Allergy       Date:  2022-03-03       Impact factor: 14.710

Review 5.  Inflammation, not Cholesterol, Is a Cause of Chronic Disease.

Authors:  Alexandros Tsoupras; Ronan Lordan; Ioannis Zabetakis
Journal:  Nutrients       Date:  2018-05-12       Impact factor: 5.717

6.  Hypersensitivity response has negligible impact on Hematopoietic Stem Cells.

Authors:  Nir Bujanover; Roshina Thapa; Oron Goldstein; Leonid Olender; Omri Sharabi; Michael D Milsom; Roi Gazit
Journal:  Stem Cell Reports       Date:  2021-07-22       Impact factor: 7.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.